Celltrion-Hospira's Inflectra wins EU nod

The European Commission approved Hospira and Celltrion's Inflectra, a biosimilar version of rheumatoid arthritis drug Remicade from Johnson & Johnson and Merck & Co. The approval makes Inflectra the first biosimilar monoclonal antibody drug cleared in the European Union.

View Full Article in:

Wall Street Journal (tiered subscription model), The · American City Business Journals

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC
Director, Health Services Analytics
Avalere Health
Washington, DC
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD